Pseudomonas aeruginosa is a persistent pathogen in the airways of patients
with cystic fibrosis or bronchiectasis from other causes and appears to hav
e evolved strategies to survive the inflammatory response of the host. We h
ypothesized that the secreted hemolytic phospholipase C (PLC) of P. aerugin
osa (PlcHR) would decrease neutrophil respiratory burst activity. We found
that while intact wild-type P, aeruginosa cells stimulated moderate respira
tory burst activity from human neutrophils, an isogenic mutant pseudomonas
(Delta HR strain) containing a targeted deletion of the plcHR operon induce
d a much more robust oxidative burst from neutrophils. In contrast, a secon
d pseudomonas mutant (Delta N) containing a disruption in the gene encoding
the nonhemolytic PLC (PlcN) was not different from the wild type in stimul
ating neutrophil O-2(-) production. Readdition of purified PlcHR to the Del
ta HR strain suppressed neutrophil O-2(-) production to levels stimulated b
y wild-type bacteria. Interestingly, purified PlcHR decreased phorbol myris
tate acetate (PMA)- but not formyl methionyl-leucyl-proline (fMLP)-induced
respiratory burst activity, suggesting interference by PlcHR with a protein
kinase C (PKC)-specific signaling pathway. Accordingly, the PKC inhibitor
bisindolylmaleimide inhibited the oxidative burst induced by either PMA or
intact pseudomonas, but not by fMLP, whereas the p38 kinase inhibitor SB-20
3580 fully inhibited the respiratory burst induced by fMLP or the PlcHR-rep
lete wild-type bacteria, but not PMA or the PLHR-deficient Delta HR bacteri
al mutant. We conclude that expression of PlcHR by P. aeruginosa suppresses
bacterium-induced neutrophil respiratory burst by interfering with a PKC-d
ependent, non-p38 kinase-dependent pathway.